Clik here to view.
Babraham confirmed as global life science power player
A newly commissioned report led by Cambridge University underlines the credentials of Babraham Research Campus (BRC) as a UK and world-class power base for life science business.The total GVA impact of...
View ArticleClik here to view.
Cambridge trio key to UK’s quantum computing leap to world leadership
A trio of bleeding-edge Cambridge companies are being funded by the Government to help propel the UK to global leadership in quantum computing.Nu Quantum, Riverlane and Arm are key players in...
View ArticleClik here to view.
Avacta hopeful for potential COVID-19 therapy after test triumph
A potential new therapy for COVID-19 infection appears to have moved closer after specific tests on Cambridge-based Avacata’s Affimer biotherapeutics and reagents.Collaborative work with the Centre for...
View ArticleClik here to view.
Cambridge AI firm says drug identified in April could have saved 5,000 lives
AI VIVO, the Cambridge company combining systems pharmacology and AI to accelerate drug discovery, reveals that its platform correctly identified dexamethasone as having high potential for the...
View ArticleClik here to view.
Illumina unveils first Cambridge cohort for global genomics accelerator
Two Cambridge companies fly the flag for the UK cluster in the first global cohort of Illumina’s genomics accelerator.Alchemab Therapeutics and Tailor Bio are among three companies that comprise the...
View ArticleClik here to view.
CIC piles on the assets in boom year for investments
Cambridge Innovation Capital expanded its portfolio to 30 companies and increased net asset value by 46 per cent to £301.7 million in the year to March 31.The successes included one unicorn (CMR...
View ArticleClik here to view.
Arm ousts Intel at heart of Apple’s new Mac magic
US tech titan Apple is celebrating Independence Day early – and for long-term Cambridge UK partner Arm the outcome is just Yankee Doodle Dandy.Thirty years after Apple backed a fledgling Arm to break...
View ArticleClik here to view.
Siemens pays millions for Cambridge’s UltraSoC
Cambridge chip technology business UltraSoC has been acquired by Texas-headquartered Siemens Digital Industries Software.While no sum has been officially announced for the acquisition it runs into the...
View ArticleClik here to view.
Kymab wins Supreme Court patent victory over US giant
Cambridge biopharma business Kymab has won a landmark UK Supreme Court verdict that invalidates patent claims by US giant Regeneron.It is the latest court victory for the Babraham-based antibodies...
View ArticleClik here to view.
Commercial Leases: Gearing up as we emerge from the pandemic
I began writing this as we approached the June quarter day when the concerns of both commercial landlords and tenants were brought into sharp relief following the tough – or non-existent – trading...
View ArticleClik here to view.
Huawei commits £1bn to first phase of Cambridge optoelectronics nervecentre
Huawei has won planning consent for the first phase of a new optoelectronics R & D and manufacturing centre in Cambridge.It will invest £1 billion in the first phase of the project which includes...
View ArticleClik here to view.
Pfizer leads $15m raise and expands alliance with Mission Therapeutics
Cambridge drug discovery business Mission Therapeutics has raised $15 million in equity investment in a round led by existing backer Pfizer Ventures, the venture capital arm of Wall Street-quoted...
View ArticleClik here to view.
GeoSpock to unveil seminal funding round to fuel global expansion
GeoSpock, the Cambridge extreme data technology pioneer, is set to wrap up a megabucks and transformational investment round within weeks to underpin further international expansion.We expect GeoSpock...
View ArticleClik here to view.
Xaar’s 30th birthday: Now, where to stick the candles!
Management at Cambridge inkjet innovator Xaar plc say they have sent champagne to all the team to mark the company’s 30th anniversary. But the harsh truth is that for shareholders the bubbly went flat...
View ArticleClik here to view.
Cambridge impact unknown as Arm divests IoT business to parent SoftBank
Superchip architect Arm has declined to go into the potential impact on its Cambridge UK headquarters of a major restructuring by its Japanese parent company SoftBank.ARM is set to to transfer two of...
View ArticleClik here to view.
Private Equity firms poised to aid recovery and fuel M & A activity
It’s clear that we’re in for a long and bumpy ride and a very gradual transition to ‘normal’, writes Tom Gallop, Corporate Finance partner at Ashcroft Partnership LLP. Many businesses face an...
View ArticleClik here to view.
£200m office development for Cambridge proposed
Mark Glatman's Abstract Securities reveals that its wholly owned subsidiary – Abstract (Cambridge) Limited – has exchanged contracts to acquire a 9.17 acre site at Fulbourn Road in Cambridge, with...
View ArticleClik here to view.
Seeds of a revolution as Spirea plans to reshape cancer treatment
University of Cambridge spin-out Spirea Limited, is targeting a potential $7.5 billion market for the treatment of multiple cancers after raising crucial seed funding.Meltwind and Start Codon have led...
View ArticleClik here to view.
Bango hits record revenue growth ahead of forecasts
Mobile payments technology business Bango saw its stock rise significantly when the UK market opened today after flagging up record revenue growth – ahead of expectations – for the first half of 2020....
View ArticleClik here to view.
Arm sale on cards as SoftBank fights for cash
Cambridge’s greatest ever technology business – superchip architect Arm – may be put up for sale by Japanese owner SoftBank just four years after it paid $32 billion to acquire the company.Goldman...
View Article